Key result
Maintenance chemotherapy linked to prolonged progression-free survival after chemoradiotherapy for head and neck cutaneous angiosarcoma.
Why the study?
Does maintenance chemotherapy improve progression-free survival in patients with localised cutaneous angiosarcoma of the head and neck who achieve a complete response after concurrent chemoradiotherapy?
Does maintenance chemotherapy improve progression-free survival in patients with localised cutaneous angiosarcoma of the head and neck who achieve a complete response after concurrent chemoradiotherapy?
In patients with localised cutaneous angiosarcoma of the head and neck, combination therapy and maintenance chemotherapy after complete response to chemoradiotherapy are associated with improved progression-free survival.
Answers are grounded in this paper and cite their sources.
May support maintenance chemotherapy after complete response; leaves open need for prospective validation in this rare malignancy.
A multicentre Japanese cohort of patients with localised cutaneous angiosarcoma of the head and neck showed that combination therapy was associated with favourable outcomes. In patients achieving a complete response after concurrent chemoradiotherapy, maintenance chemotherapy was associated with prolonged progression-free survival.
No takes yet. Share an insight, caveat, or question.
Nakano et al. (2026) studied this question. Maintenance chemotherapy prolonged progression-free survival in patients achieving complete response after concurrent chemoradiotherapy for localized head and neck cutaneous angiosarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: